Expanding Phase III Study of Tyroserleutide for Injection (Q62817802)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expanding Phase III Study of Tyroserleutide for Injection |
clinical trial |
Statements
Randomized, Double-Blind, Placebo-Controlled, Multicenter Expanding Phase III Clinical Trial to Evaluate the Safety and Efficacy of Injectable Tyroserleutide to Treat Hepatocellular Carcinoma (HCC) (After HCC Resection) (English)
0 references
24 March 2016
0 references
13 June 2016
0 references
352
0 references
18 year
0 references
75 year
0 references